{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:12:56Z","timestamp":1782756776782,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2014.78","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T09:55:27Z","timestamp":1415613327000},"page":"e259-e259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified"],"prefix":"10.1038","volume":"4","author":[{"given":"M A","family":"Laginestra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P P","family":"Piccaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Fuligni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Agostinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Sapienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mannu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Sabattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Tabanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A S","family":"Sacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T Z","family":"Barrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Etebari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Melle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cl\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Gibellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Tripodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Inghirami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"BFbcj201478_CR1","first-page":"158","volume-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2008","unstructured":"Jaffe ES, Harris NL, Stein H, Campo E, Pileri SA, Swerdlow SH et al. Introduction and overview of the classification of the lymphoid neoplasms. In Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds) WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 4th edn. IARC Lyon, France, 2008, pp 158\u2013166."},{"key":"BFbcj201478_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/sj.leu.2404046","volume":"20","author":"MJS Dyer","year":"2006","unstructured":"Dyer MJS, Siebert R . Peripheral T-cell non-Hodgkin's lymphoma NOS: naming of parts. Leukemia 2006; 20: 208\u2013209.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR3","first-page":"306","volume-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"SA Pileri","year":"2008","unstructured":"Pileri SA, Weisenburger DD, Sng I, Jaffe ES, Ralfkiaer E, Nakamura S et al. Peripheral T-cell lymphoma, not otherwise specified. In Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds) WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 4th edn. IARC Lyon, France, 2008, pp 306\u2013308."},{"key":"BFbcj201478_CR4","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical\u2013pathologic prognostic score. J Clin Oncol 2006; 24: 2472\u20132479.","journal-title":"J Clin Oncol"},{"key":"BFbcj201478_CR5","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","volume":"16","author":"V Mak","year":"2013","unstructured":"Mak V, Hamm J, Chhanabhai M, Shenkier T, Klasa R, Sehn LH et al. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol 2013; 16: 1970\u20131976.","journal-title":"J Clin Oncol"},{"key":"BFbcj201478_CR6","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","volume":"25","author":"M Cuadros","year":"2007","unstructured":"Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J et al. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol. 2007; 25: 3321\u20133329.","journal-title":"J Clin Oncol."},{"key":"BFbcj201478_CR7","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1200\/JCO.2012.42.5611","volume":"31","author":"PP Piccaluga","year":"2013","unstructured":"Piccaluga PP, Fuligni F, De Leo A, Bertuzzi C, Rossi M, Bacci F et al. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. J Clin Oncol 2013; 31: 3019\u20133025.","journal-title":"J Clin Oncol"},{"key":"BFbcj201478_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1586\/ehm.11.55","volume":"4","author":"F Roncolato","year":"2011","unstructured":"Roncolato F, Gazzola A, Zinzani PL, Pileri SA, Piccaluga PP . Targeted molecular therapy in peripheral T-cell lymphomas. Expert Rev Hematol 2011; 4: 551\u2013562.","journal-title":"Expert Rev Hematol"},{"key":"BFbcj201478_CR9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","volume":"20","author":"P Corradini","year":"2006","unstructured":"Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006; 20: 1533\u20131538.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR10","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0002-9440(10)63742-X","volume":"164","author":"A Zettl","year":"2004","unstructured":"Zettl A, Rudiger T, Konrad MA, Chott A, Simonitsch-Klupp I, Sonnen R et al. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004; 164: 1837\u20131848.","journal-title":"Am J Pathol"},{"key":"BFbcj201478_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/leu.2008.320","volume":"23","author":"AL Feldman","year":"2009","unstructured":"Feldman AL, Law M, Remstein ED, Macon WR, Erickson LA, Grogg KL et al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia 2009; 23: 574\u2013580.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/gcc.20386","volume":"46","author":"C Thorns","year":"2007","unstructured":"Thorns C, Bastian B, Pinkel D, Roydasgupta R, Fridlyand J, Merz H et al. Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: a matrix-based CGH approach. Genes Chromosomes Cancer 2007; 46: 37\u201344.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFbcj201478_CR13","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/sj.leu.2402248","volume":"10","author":"M Renedo","year":"2001","unstructured":"Renedo M, Martinez-Delgado B, Arranz E, Garcia M J, Urioste M, Martinez-Ramirez A et al. Chromosomal changes pattern and gene amplification in T cell non-Hodgkin\u2019s lymphomas. Leukemia 2001; 10: 1627\u20131632.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1365-2141.2009.07956.x","volume":"148","author":"S Hartmann","year":"2010","unstructured":"Hartmann S, Gesk S, Scholtysik R, Kreuz M, Bug S, Vater I et al. High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus. Br J Haematol 2010; 148: 402\u2013412.","journal-title":"Br J Haematol"},{"key":"BFbcj201478_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B Streubel","year":"2006","unstructured":"Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A . Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006; 20: 313\u2013318.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR16","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/leu.2008.191","volume":"22","author":"S-I Fujiwara","year":"2008","unstructured":"Fujiwara S-I, Yamashita Y, Nakamura N, Choi Y L, Ueno T, Watanabe H et al. High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays. Leukemia 2008; 22: 1891\u20131898.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR17","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1158\/1078-0432.CCR-04-0269","volume":"10","author":"B Martinez-Delgado","year":"2004","unstructured":"Martinez-Delgado B, Melendez B, Cuadros M, Alvarez J, Castrillo JM, Ruiz De La Parte A et al. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res 2004; 10: 4971\u20134982.","journal-title":"Clin Cancer Res"},{"key":"BFbcj201478_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1172\/JCI26833","volume":"117","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007; 117: 823\u2013834.","journal-title":"J Clin Invest"},{"key":"BFbcj201478_CR19","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","volume":"28","author":"R Piva","year":"2010","unstructured":"Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 2010; 28: 1583\u20131590.","journal-title":"J Clin Oncol"},{"key":"BFbcj201478_CR20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010; 115: 1026\u20131036.","journal-title":"Blood"},{"key":"BFbcj201478_CR21","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L De Leval","year":"2007","unstructured":"De Leval L, Rickman DS, Thielen C, Reynies Ad, Huang YL, Delsol G et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007; 109: 4952\u20134963.","journal-title":"Blood"},{"key":"BFbcj201478_CR22","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","volume":"25","author":"B Ballester","year":"2006","unstructured":"Ballester B, Ramuz O, Gisselbrecht C, Doucet G, Lo\u00ef L, Loriod B et al. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 2006; 25: 1560\u20131570.","journal-title":"Oncogene"},{"key":"BFbcj201478_CR23","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 2014; 123: 2915\u20132923.","journal-title":"Blood"},{"key":"BFbcj201478_CR24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","volume":"120","author":"L Agnelli","year":"2012","unstructured":"Agnelli L, Mereu E, Pellegrino E, Limongi T, Kwee I, Bergaggio E et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood 2012; 120: 1274\u20131281.","journal-title":"Blood"},{"key":"BFbcj201478_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281\u2013297.","journal-title":"Cell"},{"key":"BFbcj201478_CR26","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257\u20132261.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201478_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers [letter]. Nature 2005; 435: 834\u2013838.","journal-title":"Nature"},{"key":"BFbcj201478_CR28","doi-asserted-by":"publisher","first-page":"16228","DOI":"10.1073\/pnas.1009719107","volume":"107","author":"O Merkel","year":"2011","unstructured":"Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M et al. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK\u2212 anaplastic large-cell lymphoma. Proc Natl Acad Sci USA 2011; 107: 16228\u201316233.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201478_CR29","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/leu.2011.168","volume":"25","author":"E Dejean","year":"2011","unstructured":"Dejean E, Renalier MH, Foisseau M, Agirre X, Joseph N, de Paiva GR et al. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia 2011; 25: 1882\u20131890.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR30","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1182\/blood-2011-05-354654","volume":"118","author":"H Matsuyama","year":"2011","unstructured":"Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N et al. miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 2011; 118: 6881\u20136892.","journal-title":"Blood"},{"key":"BFbcj201478_CR31","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1182\/blood-2010-09-301994","volume":"117","author":"C Desjobert","year":"2011","unstructured":"Desjobert C, Renalier MH, Bergalet J, Dejean E, Joseph N, Kruczynski A et al. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood 2011; 117: 6627\u20136637.","journal-title":"Blood"},{"key":"BFbcj201478_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3324\/haematol.2013.088286","volume":"99","author":"E Spaccarotella","year":"2014","unstructured":"Spaccarotella E, Pellegrino E, Ferracin M, Ferreri C, Cuccuru G, Liu C et al. STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma. Haematologica 2014; 99: 116\u2013124.","journal-title":"Haematologica"},{"key":"BFbcj201478_CR33","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/leu.2013.291","volume":"28","author":"Z-X Yan","year":"2014","unstructured":"Yan Z-X, Wu L-L, Xue K, Zhang Q-L, Guo Y, Romero M et al. MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma. Leukemia 2014; 28: 880\u2013887.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR34","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1182\/blood-2012-08-447375","volume":"122","author":"C Liu","year":"2013","unstructured":"Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood 2013; 122: 2083\u20132092.","journal-title":"Blood"},{"key":"BFbcj201478_CR35","doi-asserted-by":"publisher","first-page":"e8162","DOI":"10.1371\/journal.pone.0008162","volume":"4","author":"C April","year":"2009","unstructured":"April C, Klotzle B, Royce T, Wickham-Garcia E, Boyaniwsky T, Izzo J et al. Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PloS One 2009; 4: e8162.","journal-title":"PloS One"},{"key":"BFbcj201478_CR36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/path.2728","volume":"221","author":"N Waddell","year":"2010","unstructured":"Waddell N, Cocciardi S, Johnson J, Healey S, Marsh A, Riley J et al. Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay. J Pathol 2010; 221: 452\u2013461.","journal-title":"J Pathol"},{"key":"BFbcj201478_CR37","doi-asserted-by":"publisher","first-page":"e17429","DOI":"10.1371\/journal.pone.0017429","volume":"6","author":"EA Shirdel","year":"2011","unstructured":"Shirdel EA, Xie W, Mak TW, Jurisica I . NAViGaTing the micronome-using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs. PLoS One 2011; 6: e17429.","journal-title":"PLoS One"},{"key":"BFbcj201478_CR38","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201478_CR39","first-page":"457","volume":"58","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P . Non-parametric estimation from incomplete observation. JAMA 1958; 58: 457\u2013481.","journal-title":"JAMA"},{"key":"BFbcj201478_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1586\/ehm.11.37","volume":"4","author":"PP Piccaluga","year":"2011","unstructured":"Piccaluga PP, Agostinelli C, Tripodo C, Gazzola A, Bacci F, Sabattini E et al. Peripheral T-cell lymphoma classification: the matter of cellular derivation. Expert Rev Hemat 2011; 4: 415\u2013425.","journal-title":"Expert Rev Hemat"},{"key":"BFbcj201478_CR41","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","volume":"67","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 2007; 67: 10703\u201310710.","journal-title":"Cancer Res"},{"key":"BFbcj201478_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/leu.2009.198","volume":"24","author":"RA Wilcox","year":"2010","unstructured":"Wilcox RA, Sun DX, Novak A, Dogan A, Ansell SM, Feldman AL . Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines. Leukemia 2010; 24: 229\u2013232.","journal-title":"Leukemia"},{"issue":"1","key":"BFbcj201478_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1182\/asheducation-2005.1.267","volume":"2005","author":"K. J. Savage","year":"2005","unstructured":"Savage KJ . Aggressive peripheral T-cell lymphomas (specified and unspecified types). Hematology Am Soc Hematol Educ Program 2005, 267\u2013277.","journal-title":"Hematology"},{"key":"BFbcj201478_CR44","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2008.77","volume":"22","author":"AL Feldman","year":"2008","unstructured":"Feldman AL, Sun DX, Law ME, Novak AJ, Attygalle AD, Thorland EC et al. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia 2008; 22: 1139\u20131143.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR45","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1172\/JCI61205","volume":"122","author":"SA Pileri","year":"2012","unstructured":"Pileri SA, Piccaluga PP . New molecular insights into peripheral T cell lymphomas. J Clin Invest 2012; 122: 3448\u20133455.","journal-title":"J Clin Invest"},{"key":"BFbcj201478_CR46","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D . International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124\u20134130.","journal-title":"J Clin Oncol"},{"key":"BFbcj201478_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/leu.2009.223","volume":"24","author":"W-L Zhao","year":"2010","unstructured":"Zhao W-L . Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways. Leukemia 2010; 24: 13\u201321.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nri2252","volume":"8","author":"HF Lodish","year":"2008","unstructured":"Lodish HF, Zhou B, Liu G, Chen CZ . Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8: 120\u2013130.","journal-title":"Nat Rev Immunol"},{"key":"BFbcj201478_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nri2708","volume":"10","author":"RM O\u2019Connell","year":"2010","unstructured":"O\u2019Connell RM, Rao DS, Chaudhuri AA, Baltimore D . Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111\u2013122.","journal-title":"Nat Rev Immunol"},{"key":"BFbcj201478_CR50","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/leu.2013.121","volume":"27","author":"HI Suzuki","year":"2013","unstructured":"Suzuki H I, Matsuyama H, Noguchi M, Yao T, Komatsu N, Mano H et al. Computational dissection of distinct microRNA activity signatures associated with peripheral T cell lymphoma subtypes [letter]. Leukemia 2013; 27: 2107\u20132111.","journal-title":"Leukemia"},{"key":"BFbcj201478_CR51","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ijc.25818","volume":"129","author":"W Wang","year":"2011","unstructured":"Wang W, Peng B, Wang D, Ma X, Jiang D, Zhao J et al. Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets. Int J Cancer 2011; 129: 1624\u20131634.","journal-title":"Int J Cancer"},{"key":"BFbcj201478_CR52","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/carcin\/bgr105","volume":"32","author":"S Zhang","year":"2011","unstructured":"Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J et al. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis 2011; 32: 1183\u20131189.","journal-title":"Carcinogenesis"},{"key":"BFbcj201478_CR53","unstructured":"Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, 4th edn. IARC: Lyon, France, 2008."},{"key":"BFbcj201478_CR54","unstructured":"Federico M, Bellei M, Pesce EA, Zucca E, Pileri S, Montoto S et al. T-cell project: an international, prospective, observational study of patients with aggressive peripheral T-cell lymphoma\u2014analysis of first 524 patients. Ann Oncol 2011; 22 (Suppl. 4)iv164\u2013iv167(abstract 241)."}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201478","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:57:24Z","timestamp":1672959444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,7]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11]]}},"alternative-id":["BFbcj201478"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2014.78","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,7]]},"assertion":[{"value":"15 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}